Osawa Y, Yoshida A, Asaga T, Kawahara S, Yanoma S
Second Division of Surgery, Kanagawa Cancer Center, Japan.
Gan To Kagaku Ryoho. 1996 Mar;23(4):471-6.
In the current study, we ran a chemosensity test on 7 human undifferentiated carcinoma cell lines against 10 anticancer compounds using MTT assay. Efficacy was estimated by comparing fifty percent inhibitory concentration (IC50) with the peak plasma concentration. The results showed that the 7 cell lines could be divided into two groups which had different (high or low) chemosensitivity, and that in the high sensitivity group, ACD, VCR, and etoposide were indicated as useful drugs. Our results suggest that it may be impossible to rescue all undifferentiated carcinoma patients by chemotherapy alone because the tumor may consist of 2 clones which have a different chemosensitivity.
在当前研究中,我们使用MTT法对7种人未分化癌细胞系针对10种抗癌化合物进行了化学敏感性测试。通过将半数抑制浓度(IC50)与血浆峰值浓度进行比较来评估疗效。结果显示,这7种细胞系可分为两组,其化学敏感性不同(高或低),并且在高敏感性组中,ACD、VCR和依托泊苷被表明为有效药物。我们的结果表明,仅通过化疗可能无法挽救所有未分化癌患者,因为肿瘤可能由具有不同化学敏感性的2个克隆组成。